| NCT03505034 | Intrathecal Transplantation of UC-MSC in Patients With Late Stage of Chronic Spinal Cord Injury | Third Affiliated Hospital, Sun Yat-Sen University | | - Age 18 - 65 yrs
- Level C1-S5
AIS A, B, C, D- 12 months - 65 years
- have a traumatic spinal cord injury for at least 12 months.
- have one of the following ASIA impairment scale (AIS):
- AIS A: complete; no feeling or movement below the injury,
- AIS B: incomplete; have some feeling, but no movement, below the injury,
- AIS C: incomplete; at least some feeling and mostly weak movement below the injury,
- AIS D: incomplete; at least some feeling and, some weak but mostly stronger movement below the injury.
- be between the ages of 18 and 65 years.
| | 43 | PHASE2 | Biological/cell based | General health | | | 01 September 2019 | 23 April 2018 | 1 | |
| NCT03472599 | Chronic Electrical Stimulation to Reduce Bladder Hyperreflexia | VA Office of Research and Development | | - Age ≥ 18 yrs
- Level C1-S5
AIS A, B, C, D- ≥ 6 months
| Ended | 17 | NA | Technology | Bladder health/function | | | 01 November 2019 | 21 March 2018 | 2 | |
| NCT03364660 | Task-specific Epidural Stimulation Study | University of Louisville | | - Age ≥ 18 yrs
- Level C1-S5
AIS A, B, C, D- ≥ 2 years
- NOT have ability to move legs or stand on own
| Recruiting | 36 | NA | Technology | General health | | | 08 November 2017 | 06 December 2017 | 1 | |
| NCT03345576 | Testosterone and Long Pulse Stimulation After SCI | VA Office of Research and Development | | - Age 18 - 70 yrs
- Level T10-S5
AIS A, B- ≥ 0 hours
| Ended | 12 | PHASE2 | Drug | Standing/walking/mobility | | | 01 July 2018 | 17 November 2017 | 1 | |
| NCT03267810 | TENS Trial to Prevent Neuropathic Pain in SCI | University of Miami | | - Age ≥ 18 yrs
- Level C1-S5
AIS A, B, C, D- ≤ 4 months
| Ended | 31 | NA | Technology | Pain | | | 14 August 2017 | 30 August 2017 | 1 | |
| NCT03292315 | Once Weekly GLP-1 in Persons With Spinal Cord Injury | James J. Peters Veterans Affairs Medical Center | | - Age 18 - 69 yrs
- Level C1-S5
AIS D- 3 months - 69 years
| Ended | 5 | PHASE4 | Drug | General health | | | 16 October 2018 | 25 September 2017 | 1 | |
